Optimization of formulation variables of benzocaine liposomes using experimental design

Journal of Liposome Research

Volumn 18, Issue 2, 2008, Pages 113-125

  Mura, Paola ^a   Capasso, Gaetano ^a   Maestrelli, Francesca ^a   Furlanetto, Sandra ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Anaesthetic activity; Benzocaine; Effect of additives; Experimental design; Liposomes

Indexed keywords

ALCOHOL; BENZOCAINE; CARBOMER; CHOLESTEROL; DICETHYLPHOSPHATE; GLYCYRRHIZIC ACID; LIPOSOME; OCTADECYLAMINE; SURFACTANT;

ANESTHESIA; ANIMAL EXPERIMENT; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; DRUG PENETRATION; ENCAPSULATION; HYDRATION; MALE; NONHUMAN; PRIORITY JOURNAL;

ADMINISTRATION, TOPICAL; AMINES; ANESTHETICS, LOCAL; ANIMALS; BENZOCAINE; DRUG DELIVERY SYSTEMS; DRUG DESIGN; DRUG STABILITY; GLYCYRRHIZIC ACID; HUMANS; LIPOSOMES; MALE; PHOSPHORIC ACID ESTERS; RABBITS; SURFACE-ACTIVE AGENTS;

EID: 45749106338     PISSN: 08982104     EISSN: 15322394     Source Type: Journal    
DOI: 10.1080/08982100802118540     Document Type: Article

References (31)

1. Anderson, M., Omri, A. (2004). The effect of different lipid components on the in vitro stability and release kinetics of liposome formulations. Drug Delivery 11:33-39.
2. Barclay, L., Vega, C. (2004). Methaemoglobinaemia linked to topical benzocaine use. Arch Intern Med 164:1192-1195.
3. Broudiscou, A., Leardi, R., Phan-Tan-Luu, R. (1996). Genetic algorithm as a tool for selection of D-optimal design. Chem Intell Lab Sys 35:105-116.
4. Bucalo, B.D., Mirikitani, E.J., Moy, R.L. (1998). Comparison of skin anaesthetic effect of liposomal lidocaine, nonliposomal lidocaine and EMLA using 30-minute application time. Dermatol Surg 24:537-541.
5. Covino, B.G., Vassallo, H. (1976): Local anaesthetics: mechanisms of action and clinical use. New York: Grune and Stratton (Eds.)
6. El Samaligy, M.S., Afifin, N., Mahmoude, E.A. (2006). Increasing bioavailability of silymarin using a buccal liposomal delivery system: preparation and experimental design investigation. Int J Pharm 308:140-148.
7. Fang, J., Hwang, T., Huang, Y., Fang, C. (2006). Enhancement of transdermal delivery of catechins by liposomes incorporating anionic surfactants and ethanol. Int J Pharm 310:131-138.
8. Fisher, R., Hung, O., Mezei, R., Stewart, M. (1998). Topical anaesthesia of intact skin: liposome-encapsulated tetracaine vs EMLA. Br J Anaest 81:972-973.
9. Fresta, M., Puglisi G. (1996). Application of liposomes as potential cutaneous drug delivery systems: in vitro and in vivo investigation with radioactivity labelled vesicles. J Drug Target 4:95-101.
10. Furlanetto, S., Cirri, M., Maestrelli, F., Corti, G., Mura, P. (2006). Study of formulation variables influencing the drug release rate from matrix tablets by experimental design. Eur J Pharm Biopharm 62:77-84.
11. Gabrielsson, J., Lindberg, N.O., Lundstedt, T., 2002. Multivariate methods in pharmaceutical applications. J Chemometrics 16:141-160.
12. Ghelardini, C., Galeotti, N., Di Cesare Mannelli, L., Mazzanti, G. Bartolini, A. (2001). Local anaesthetic activity of β- caryophyllene. Il Farmaco 56:387-389.
13. Grant, G.J., Bansinath, M. (2001). Liposomal delivery systems for local anaesthetics. Reg Anesth Pain Med 26:61-63.
14. Kirjavainen, M., Urtti, A., Jaaskelainen, I., Suhonen, T.M., Paronen, P., Valjakka-Koskela, R., Kiesvaara, J., Monkkonen, J. (1996). Interaction of liposomes with human skin in vitro-the influence of lipid composition and structure. Biochim Biophys Acta 1304:179-189.
15. Kirjavainen, M., Urtti, A., Valjakka-Koskela, R., Kiesvaara, J., Monkkonen, J. (1999). Liposome-skin interactions and their effects on the skin permeation of drugs. Eur J Pharm Sci 7:279-286.
16. Lewis, G.A., Mathieu, D., Phan-Tan-Luu, R. (1999). Pharmaceutical experimental design. New York: Marcel Dekker (ed).
17. Lim, J.O., Kim, S.J., Pouliot, R., Baek, W.Y. (2005). Enhanced transdermal delivery of local anaesthetics by liposome formulation of local anaesthetic mixture. Trans Tech Publ 277:45-50.
18. López-Pinto, J.M., Gonzalez-Rodriguez, M.L., Rabasco, A.M. (2005). Effect of cholesterol and ethanol on dermal delivery from DPPC liposomes. Int J Pharm 298:1-12.
19. Maestrelli, F., González-Rodríguez, M.L., Rabasco, A.M., Mura, P. (2005). Preparation and characterisation of liposomes encapsulating ketoprofen-cyclodextrin complexes for transdermal drug delivery. Int J Pharm 298:55-67.
20. Margalit, R. (1995). Liposome-mediated drug targeting in topical and regional therapies. Crit Rev Ther Drug Carrier Syst 12:233-261.
21. Mathieu, D., Nony, J., Phan-Tan-Luu, R. (2000). NEMRODW software, LPRAI sarl, Marseille, F-13331, France.
22. Mezei, M., Gulasekharam, V. (1982). Liposomes, a selective drug delivery system for the topical route of administration: gel dosage form. J Pharm Pharmacol 34:473-474.
23. Mohammed, A.R., Weston, N., Coombes, A.G.A., Fitzgerald, M., Perrie, Y. (2004). Liposome formulation of poorly water soluble drugs: optimisation of drug loading and ESEM analysis of stability. Int J Pharm 285:23-34.
24. Mura, P., Celesti, L., Murratzu, C., Corsi, S., Furlanetto, S., Corti, P. (1993). In vitro studies of simulated percutaneous absorption: influence of artificial membrane impregnation agent. Acta Techn Leg Med 4:121-136.
25. Mura, P., Maestrelli, F., Michelacci, I., Ghelardini, C., Gonzalès, M.L., Rabasco, A. (2007). Development, characterization and in vivo evaluation of benzocaine-loaded liposomes. Eur J Pharm Biopharm 67:86-95.
26. Seth, A.K., Misra, A. (2002). Matematical modelling of preparation of acyclovir liposomes: reverse phase evaporation method. J Pharm Pharmaceut Sci 5:285-291.
27. Sun, X., Zhang, Z. (2004). Optimizing the novel formulation of liposome-polycation-DNA complexes (LPD) by central composite design. Arch Pharm Res 27:797-805.
28. Touitou, E., Alkabes, M., Dayan, N., Elbaz, M. (1997). Ethosomes: novel vesicular carriers for enhanced skin delivery. Pharm Res 14:305-306.
29. Trotta, M., Peira, E., Carlotti, M.E., Gallarate, M. (2004). Deformable liposomes for dermal administration of methotrexate. Int J Pharm.270:119-125.
30. Verma, D.D., Verma, S., Blume, G., Fahr, A. (2003). Liposomes increase skin penetration of entrapped and non-entrapped hydrophilic substances into human skin: a skin penetration and confocal laser scanning microscopy study. Eur J Pharm Biopharm 55:271-277.
31. Webb, M.S., Wheeler, J.J., Bally, M.B., Mayer, L.D. (1995). Cationic lipid stearylamine reduces permeability of cationic drugs verapamil and prochlorperazine to lipid bilayer: implications for drug delivery. Biochim Biophys Acta 1238:147-155.